Numb− MECs derived from PDXs treated in vivo with Nutlin‐3, either alone or in combination with paclitaxel, displayed significant reduction in SFE and tumor formation (Fig 7, middle and right), accompanied by decreased ALDH activity or reduced number of CD44+/CD24− cells (Appendix Fig S5). Here, CD44 is linked to neoplasm.